
© 2024 Der Aktionär
Realtime | Geld | Brief | Zeit |
---|---|---|---|
73,96 | 75,06 | 04.04. | |
73,94 | 75,42 | 04.04. |
Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
20.03. | The Analyst Verdict: Blueprint Medicines In The Eyes Of 14 Experts | ||
20.03. | Morgan Stanley sets Blueprint Medicines stock at Equalweight, $100 target | ||
18.03. | Wolfe Research initiates Blueprint Medicines with Outperform rating | ||
17.03. | This Blueprint Medicines Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday | ||
17.03. | Jefferies sets Blueprint Medicines stock Buy rating, $135 target |
Unternehmen / Aktien | Kurs | % |
---|---|---|
BLUEPRINT MEDICINES CORPORATION | 73,04 | -2,22 % |